JMF
TXG icon

Johnson Midwest Financial’s 10x Genomics TXG Stock Holding History

Johnson Midwest Financial’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$578 Hold
14
– – ﹤0.01% 355
2023
Q2 		$782 Hold
14
– – ﹤0.01% 343
2023
Q1 		$781 Hold
14
– – ﹤0.01% 358
2022
Q4 		$1K Buy
+14
New +$458 ﹤0.01% 366

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Johnson Midwest Financial's TXG Position: Q3 2023 in Review

Johnson Midwest Financial held its 10x Genomics (TXG) position steady in Q3 2023 at 14 shares worth $578. The position accounts for ﹤0.01% of the portfolio, ranked #355.

Johnson Midwest Financial first reported a position in TXG in Q4 2022 and has held it in 4 quarters since. The position peaked at $1K in Q4 2022. 256 funds tracked by Wall St. Rank hold TXG as of Q3 2023.

  • Johnson Midwest Financial held 14 shares of 10x Genomics worth $578 as of Q3 2023.
  • Johnson Midwest Financial left its 10x Genomics share count unchanged in Q3 2023.
  • 10x Genomics made up ﹤0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #355 holding.
  • Johnson Midwest Financial first reported a position in 10x Genomics in Q4 2022 and has held it in 4 quarters since.
  • Johnson Midwest Financial's 10x Genomics position peaked at $1K in Q4 2022.
  • 256 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.